Philip S. Low - Director at Quince Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
QNCX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Philip S. Low since 10/6/2023

Holdings reported by Philip S. Low for Quince Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 455K $428K $0.94 May 19, 2022 Direct
Common Stock 64K $60.1K $0.94 May 19, 2022 By Philip S. Low Revocable Trust
Stock Option (right to buy) 22.1K May 19, 2022 Direct Common Stock

Transactions reported by Philip S. Low for Quince Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.